Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 11,850.00
Ask: 12,300.00
Change: 0.00 (0.00%)
Spread: 450.00 (3.797%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,190.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ireland Eyes Vaccines For All Adults By September Despite Supply Fears

Tue, 26th Jan 2021 16:10

(Alliance News) - Ireland's target remains to vaccinate every adult in the country by September, despite disruptions to the supply chain, the upper house of the country's legislature, has heard.

Junior Minister Anne Rabbitte, speaking on behalf of the Health Minister, said the Irish government has "significant concerns" that one vaccine producer, AstraZeneca PLC, will be unable to meet its initial delivery commitments.

This has led to some "adjustments" to the government's target of vaccinating 700,000 people by the end of March, Rabbitte said.

The goal of vaccinating all adults by September remains the target, but it is contingent on steady flow of vaccines.

Rabbitte said: "The minister for health previously stated that he expected all adult residents to be vaccinated by September.

"That remains our target.

"However, as Minister Donnelly stressed, it is contingent on existing commitments on the approval, supply and delivery of vaccines."

The AstraZeneca vaccine is crucial to the government's planned vaccine delivery schedule.

It is scheduled for approval by the European Medicines Agency on Friday, but the company recently announced it will initially supply considerably fewer doses than agreed with the EU.

The announcement has caused outrage in the EU, which pre-financed the production and delivery of the vaccine.

The new delivery schedule is "not acceptable", European Health Commissioner Stella Kyriakides has warned the company.

On Tuesday, Rabbitte also criticised the company over the delays.

She said: "Of significant concern is the recent indication that AstraZeneca will not be available to meet its initial delivery commitments.

"It is estimated that deliveries in February will be at the low range of what was anticipated, and there will be further significant impact in March.

"The Department of Health is monitoring this change of situation, and is continually engaging with the commission and the company.

"The minister is very concerned that this supply issue was only communicated to the member states just a week before the scheduled authorisation was to be given for the vaccine."

Rabbitte also warned that the arrival of the vaccines and the prospect of a return to normality "gives rise to public expectation that cannot be met in the short term".

The EU had expected to receive 100 million doses of the AstraZeneca vaccine in the first quarter of the year.

It is now feared it will receive only half that amount.

Brussels has threatened to block exports of Covid-19 vaccines outside of the bloc as a result of the ongoing row.

As of Sunday, the HSE has administered 143,000 vaccine doses in Ireland.

Two doses delivered three or four weeks apart are required for the vaccines currently in use in Ireland, Pfizer Inc/BioNTech SE and Moderna Inc.

The HSE began administration of the second doses of the vaccine last week.

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

Read more
23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

Read more
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 07:43

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.